Shenkang Injection and Its Three Anthraquinones Ameliorates Renal Fibrosis by Simultaneous Targeting IƙB/NF-ƙB and Keap1/Nrf2 Signaling Pathways

• Auteurs principaux: Liang-Pu Luo (Auteur), Ping Suo (Auteur), Li-Li Ren (Auteur), Hong-Jiao Liu (Auteur), Yamei Zhang (Auteur), Ying-Yong Zhao (Auteur)
• Format: Livre
• Publié: Frontiers Media S.A., 2021-12-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Oxidative stress and inflammation are important and critical mediators in the development and progression of chronic kidney disease (CKD) and its complications. Shenkang injection (SKI) has been widely used to treat patients with CKD. Although the anti-oxidative and anti-inflammatory activity was in...